Investigational Site Number :2760001

Frankfurt am Main 60590

0 studies enrolling now · 4 studies all time

What they study most

Hemophilia A, Psoriasis, Thrombotic Thrombocytopenic Purpura

Studies at this site

• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura — Completed
• A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis — Completed
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed